Splash Beverage Group (SBEV) investor relations material

Executive summary

• Revenue for Q1 2026 was $4,224, a sharp decline from $68,606 in Q1 2025, reflecting a lack of working capital and limited product sales, with only Chispo tequila generating revenue through Senor Frog locations.

• The company is transitioning from beverage sales to focus on the regulated wellness and cannabinoid markets, highlighted by a proposed acquisition of Medterra CBD, LLC, though the deal remains pending.

• The Copa Di Vino product line has been discontinued and its results are now classified as discontinued operations.

Financial highlights

• Net loss from continuing operations for Q1 2026 was $2.14 million, compared to $3.28 million in Q1 2025.

• Operating expenses decreased to $980,818 from $1,683,847 year-over-year, mainly due to reduced contract services, salaries, and marketing.

• Interest expense increased to $889,455 from $637,345, primarily due to the Decathlon loan.

• Net cash used in operating activities was $930,492, while net cash provided by financing activities was $1,053,541 for Q1 2026.

• Cash and cash equivalents at March 31, 2026 were $381,195, up from $281,435 at year-end 2025.

Outlook and guidance

• The company does not have sufficient capital to meet working capital needs for the next 12 months and is dependent on raising additional funds, including $10 million needed to close the Medterra acquisition.

• Management expects the Medterra acquisition, if completed, to restore compliance with NYSE American equity requirements.